Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Non-InterventionaL Study To EXplore the Real-Life MAnagement Of Postmenopausal womeN With Hormone Receptor- Positive, Human EpiDermal Growth Factor Receptor 2-Negative Locally Advanced/ MetastatIc BreAst Cancer In Egypt

NCT03583463 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03583463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03583463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Non-InterventionaL Study To EXplore the Real-Life MAnagement Of Postmenopausal womeN With Hormone Receptor- Positive, Human EpiDermal Growth Factor Receptor 2-Negative Locally Advanced/ MetastatIc BreAst Cancer In Egypt
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 29, 2018
Completion date
January 24, 2021
Enrollment
436 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer